The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules

Biomaterials

Volumn 29, Issue 16, 2008, Pages 2453-2463

  McGuigan, Alison P ^a   Sefton, Michael V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Collagen; Endothelial cells; Thrombogenicity; Tissue engineering; Vascularization; Whole blood

Indexed keywords

BLOOD; COLLAGEN; NUTRIENTS; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

NUTRIENT DELIVERY; THROMBOGENICITY; WHOLE BLOOD;

ENDOTHELIAL CELLS;

ANTIBODY; COLLAGEN GEL; HEPARIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING TIME; BLOOD FLOW; CALCIFICATION; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EQUIPMENT DESIGN; FILM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PERFUSION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOGENICITY; TISSUE ENGINEERING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; CELLS, CULTURED; COLLAGEN; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; PERFUSION; PLATELET ACTIVATION; PLATELET-RICH PLASMA; THROMBOSIS; TISSUE ENGINEERING; UMBILICAL VEINS;

EID: 40949088882     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.02.010     Document Type: Article

References (47)

1. Nomi M., Atala A., Coppi P.D., and Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med 23 6 (2002) 463-483
2. McGuigan A.P., and Sefton M.V. Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci U S A 103 31 (2006) 11461-11466
3. Gorbet M.B., and Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25 26 (2004) 5681-5703
4. McGuigan A.P., and Sefton M.V. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 28 16 (2007) 2547-2571
5. Pearson J.D. Endothelial cell function and thrombosis. Baillieres Best Pract Res Clin Haematol 12 3 (1999) 329-341
6. Davie E.W., Fujikawa K., and Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30 43 (1991) 10363-10370
7. Esmon C.T. Coagulation inhibitors in inflammation. Biochem Soc Trans 33 Pt 2 (2005) 401-405
8. Slupsky J.R., Kalbas M., Willuweit A., Henn V., Kroczek R.A., and Muller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80 6 (1998) 1008-1014
9. Schorer A.E.M.C.F. Production of tissue factor. In: Ryan U.S. (Ed). Endothelial cells (1988), CRC Press
10. Esmon C.T. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9 10 (1995) 946-955
11. Esmon C.T. Regulation of blood coagulation. Biochim Biophys Acta 1477 1-2 (2000) 349-360
12. Sandset P.M. Tissue factor pathway inhibitor (TFPI)-an update. Haemostasis 26 Suppl. 4 (1996) 154-165
13. Marcum J.A., McKenney J.B., and Rosenberg R.D. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J Clin Invest 74 2 (1984) 341-350
14. Radomski M.W., Palmer R.M., and Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148 3 (1987) 1482-1489
15. Moncada S. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. Br J Pharmacol 76 1 (1982) 3-31
16. Andrews R.K., and Berndt M.C. Platelet physiology and thrombosis. Thromb Res 114 5-6 (2004) 447-453
17. Garlanda C., and Dejana E. Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17 7 (1997) 1193-1202
18. Tedesco F., Fischetti F., Pausa M., Dobrina A., Sim R.B., and Daha M.R. Complement-endothelial cell interactions: pathophysiological implications. Mol Immunol 36 4-5 (1999) 261-268
19. Lidington E.A., Haskard D.O., and Mason J.C. Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood 96 8 (2000) 2784-2792
20. Hamilton K.K., Ji Z., Rollins S., Stewart B.H., and Sims P.J. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59. Blood 76 12 (1990) 2572-2577
21. Schwartz S.M., Heimark R.L., and Majesky M.W. Developmental mechanisms underlying pathology of arteries. Physiol Rev 70 4 (1990) 1177-1209
22. Grabowski E.F., Reininger A.J., Petteruti P.G., Tsukurov O., and Orkin R.W. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 21 1 (2001) 157-162
23. Malek A.M., Jackman R., Rosenberg R.D., and Izumo S. Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circ Res 74 5 (1994) 852-860
24. Schnaper H.W., and Kleinman H.K. Regulation of cell function by extracellular matrix. Pediatr Nephrol 7 1 (1993) 96-104
25. Hordijk P.L., Anthony E., Mul F.P., Rientsma R., Oomen L.C., and Roos D. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci 112 Pt 12 (1999) 1915-1923
26. Gulino D., Delachanal E., Concord E., Genoux Y., Morand B., Valiron M.O., et al. Alteration of endothelial cell monolayer integrity triggers resynthesis of vascular endothelium cadherin. J Biol Chem 273 45 (1998) 29786-29793
27. She M., McGuigan A.P., and Sefton M.V. Tissue factor and thrombomodulin expression on endothelial cell-seeded collagen modules for tissue engineering. J Biomed Mater Res A 80 2 (2007) 497-504
28. McGuigan A.P., and Sefton M.V. Design and fabrication of sub-mm-sized modules containing encapsulated cells for modular tissue engineering. Tissue Eng 13 5 (2007) 1069-1078
29. McGuigan A.P., Leung B., and Sefton M.V. Fabrication of cell-containing gel modules to assemble modular tissue-engineered constructs. [corrected]. Nat Protoc 1 6 (2006) 2963-2969
30. Wissink M.J., Beernink R., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., et al. Relation between cell density and the secretion of von Willebrand factor and prostacyclin by human umbilical vein endothelial cells. Biomaterials 22 16 (2001) 2283-2290
31. Gemmell C.H., Ramirez S.M., Yeo E.L., and Sefton M.V. Platelet activation in whole blood by artificial surfaces: identification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. J Lab Clin Med 125 2 (1995) 276-287
32. Gorbet M.B., and Sefton M.V. Leukocyte activation and leukocyte procoagulant activities after blood contact with polystyrene and polyethylene glycol-immobilized polystyrene beads. J Lab Clin Med 137 5 (2001) 345-355
33. Wissemann K.W., and Jacobson B.S. Pure gelatin microcarriers: synthesis and use in cell attachment and growth of fibroblast and endothelial cells. In Vitro Cell Dev Biol 21 7 (1985) 391-401
34. McGuigan A.P., and Sefton M.V. Design criteria for a modular tissue-engineered construct. Tissue Eng 13 5 (2007) 1079-1089
35. Levene H. In: Olkin I. (Ed). Contributions to probability and statistics (1960), Stanford University Press, Palo Alto, CA
36. Zolman J.F. Biostatistics (1993), Oxford University Press, Oxford p. 151
37. Kirchhofer D., Sakariassen K.S., Clozel M., Tschopp T.B., Hadvary P., Nemerson Y., et al. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 81 8 (1993) 2050-2058
38. Kirchhofer D., Tschopp T.B., Hadvary P., and Baumgartner H.R. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 93 5 (1994) 2073-2083
39. Diquelou A., Dupouy D., Gaspin D., Constans J., Sie P., Boneu B., et al. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb Haemost 74 2 (1995) 778-783
40. Diquelou A., Lemozy S., Dupouy D., Boneu B., Sakariassen K., and Cadroy Y. Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood 84 7 (1994) 2206-2213
41. Biedermann B., Rosenmund A., Muller M., Kohler H.P., Haeberli A., and Straub P.W. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro. J Lab Clin Med 124 3 (1994) 339-347
42. Bombeli T., Muller M., Straub P.W., and Haeberli A. Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood. J Lab Clin Med 127 6 (1996) 621-634
43. Kohler H.P., Muller M., Bombeli T., Straub P.W., and Haeberli A. The suppression of the coagulation of nonanticoagulated whole blood in vitro by human umbilical endothelial cells cultivated on microcarriers is not dependent on protein C activation. Thromb Haemost 73 4 (1995) 719-724
44. Sosnik A., and Sefton M.V. Semi-synthetic collagen/poloxamine matrices for tissue engineering. Biomaterials 26 35 (2005) 7425-7435
45. Hedeman Joosten P.P., Verhagen H.J., Heijnen-Snyder G.J., van Vroonhoven T.J., Sixma J.J., de Groot P.G., et al. Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions. J Vasc Surg 28 6 (1998) 1094-1103
46. Zwaginga J.J., de Boer H.C., IJsseldijk M.J., Kerkhof A., Muller-Berghaus G., Gruhlichhenn J., et al. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis 10 3 (1990) 437-448
47. Hedeman Joosten P.P., Verhagen H.J., Heijnen-Snyder G.J., Sixma J.J., de Groot P.G., Eikelboom B.C., et al. Thrombomodulin activity of fat-derived microvascular endothelial cells seeded on expanded polytetrafluorethylene. J Vasc Res 36 2 (1999) 91-99